The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trial
about
Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infectionGut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunityGut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression.Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.Inflammation, immune activation, and cardiovascular disease in HIV.Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study.Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV InfectionThe Alphabet Soup of HIV Reservoir Markers.Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis.Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy.Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC+ CD4+ cell levels: a surrogate marker candidate of HIV-induced intestinal damage.
P2860
Q26748743-34352A61-9B2E-49F1-9CC2-72DF4387B4FBQ26773267-9D5FCB67-4163-4CC5-B637-C39D67695E7CQ36132003-8EEC467D-D3CC-4A9F-ABC1-5D010B1EEB96Q36607484-F67A8CB4-BFD5-4F94-BF8C-AF60162534FDQ36957752-3EA5289D-B6DA-4B7D-A91F-3DDC458F3A54Q36961578-49DA5B4B-9C8C-42D4-8732-C6E267725391Q37413059-CC64B9CA-40C1-4969-88D6-C17140AE9B5AQ38603237-2C02AA3D-50CE-4EC6-9C8B-C454636EEE3DQ38749963-56B9A084-F0CA-40FA-8271-58AB2083163BQ39237000-A1973FB5-C9F1-4833-8123-670060544A0DQ39249817-69FF0FA8-AAE9-45A2-8DD6-137A054FD99EQ45326424-CFA61A10-75C5-4DCE-8CDC-2F0890D01FC5Q55605404-511859E8-83C8-42F8-9B23-0B06EB460F59
P2860
The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trial
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The immunologic effects of mes ...... : a randomized crossover trial
@ast
The immunologic effects of mes ...... : a randomized crossover trial
@en
The immunologic effects of mes ...... : a randomized crossover trial
@nl
type
label
The immunologic effects of mes ...... : a randomized crossover trial
@ast
The immunologic effects of mes ...... : a randomized crossover trial
@en
The immunologic effects of mes ...... : a randomized crossover trial
@nl
prefLabel
The immunologic effects of mes ...... : a randomized crossover trial
@ast
The immunologic effects of mes ...... : a randomized crossover trial
@en
The immunologic effects of mes ...... : a randomized crossover trial
@nl
P2093
P2860
P1433
P1476
The immunologic effects of mes ...... : a randomized crossover trial
@en
P2093
Jeffrey Lifson
Jeffrey N Martin
Joseph M McCune
Ma Somsouk
Michael Piatak
Michelle Cohen
Mohamed Abdel-Mohsen
Peter W Hunt
Priscilla Y Hsue
Rebecca Albright
P2860
P304
P356
10.1371/JOURNAL.PONE.0116306
P407
P577
2014-12-29T00:00:00Z